Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00LSZ
|
|||
Former ID |
DNC009841
|
|||
Drug Name |
N,8-dihydroxy-8-(naphthalen-2-yl)octanamide
|
|||
Synonyms |
CHEMBL319738; N,8-dihydroxy-8-(naphthalen-2-yl)octanamide; SCHEMBL3382032; JWCSCYWHCCHTEF-UHFFFAOYSA-N; BDBM50114820; N-Hydroxy-8-hydroxy-8-(2-naphthyl)octanamide; 8-Hydroxy-8-naphthalen-2-yl-octanoic acid hydroxyamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H23NO3
|
|||
Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)C(CCCCCCC(=O)NO)O
|
|||
InChI |
1S/C18H23NO3/c20-17(9-3-1-2-4-10-18(21)19-22)16-12-11-14-7-5-6-8-15(14)13-16/h5-8,11-13,17,20,22H,1-4,9-10H2,(H,19,21)
|
|||
InChIKey |
JWCSCYWHCCHTEF-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.